Karl Vandepoele

672 total citations
23 papers, 428 citations indexed

About

Karl Vandepoele is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Karl Vandepoele has authored 23 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Hematology and 4 papers in Genetics. Recurrent topics in Karl Vandepoele's work include Acute Myeloid Leukemia Research (4 papers), Neuroblastoma Research and Treatments (4 papers) and Iron Metabolism and Disorders (3 papers). Karl Vandepoele is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Neuroblastoma Research and Treatments (4 papers) and Iron Metabolism and Disorders (3 papers). Karl Vandepoele collaborates with scholars based in Belgium, Democratic Republic of the Congo and Netherlands. Karl Vandepoele's co-authors include Frans van Roy, Katrien Staes, Nadine Van Roy, Frank Speleman, Vanessa Andries, Jan Philippé, Geert Berx, Barbara Denys, Geneviève Laureys and Els De Smet and has published in prestigious journals such as Blood, PLoS ONE and Molecular Biology and Evolution.

In The Last Decade

Karl Vandepoele

22 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karl Vandepoele Belgium 12 256 122 79 64 55 23 428
Cecilia Surace Italy 12 328 1.3× 201 1.6× 128 1.6× 66 1.0× 68 1.2× 33 595
Rodney Staggs United States 7 385 1.5× 74 0.6× 90 1.1× 118 1.8× 121 2.2× 8 556
Pietro Sirleto Italy 12 221 0.9× 137 1.1× 31 0.4× 31 0.5× 44 0.8× 25 399
Josef Davidsson Sweden 11 191 0.7× 165 1.4× 40 0.5× 123 1.9× 49 0.9× 16 442
P. Mollevanger Netherlands 13 196 0.8× 189 1.5× 32 0.4× 65 1.0× 52 0.9× 19 428
Nicole L. Hoppman United States 14 279 1.1× 279 2.3× 92 1.2× 173 2.7× 55 1.0× 62 704
Philippe Coullin France 15 268 1.0× 208 1.7× 32 0.4× 22 0.3× 23 0.4× 28 526
Patrick A. Ozark United States 13 619 2.4× 61 0.5× 66 0.8× 73 1.1× 65 1.2× 15 754
Vasilios Zachariadis Sweden 11 157 0.6× 90 0.7× 50 0.6× 100 1.6× 38 0.7× 20 392
Jürgen Groet United Kingdom 12 213 0.8× 98 0.8× 31 0.4× 243 3.8× 41 0.7× 15 502

Countries citing papers authored by Karl Vandepoele

Since Specialization
Citations

This map shows the geographic impact of Karl Vandepoele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Vandepoele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Vandepoele more than expected).

Fields of papers citing papers by Karl Vandepoele

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl Vandepoele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Vandepoele. The network helps show where Karl Vandepoele may publish in the future.

Co-authorship network of co-authors of Karl Vandepoele

This figure shows the co-authorship network connecting the top 25 collaborators of Karl Vandepoele. A scholar is included among the top collaborators of Karl Vandepoele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl Vandepoele. Karl Vandepoele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Moerloose, Barbara De, Karl Vandepoele, Anne Uyttebroeck, et al.. (2020). Deciphering molecular heterogeneity in pediatric AML using a cancer vs. normal transcriptomic approach. Pediatric Research. 89(7). 1695–1705. 12 indexed citations
3.
4.
Uyttebroeck, Anne, An Van Damme, Alina Ferster, et al.. (2019). Deciphering Molecular Heterogeneity in Pediatric AML Using a Cancer Vs Normal Transcriptomic Approach. Blood. 134(Supplement_1). 1457–1457. 3 indexed citations
5.
Denys, Barbara, Gertjan J.L. Kaspers, Jeroen J. W. M. Janssen, et al.. (2018). RNA-based FLT3-ITD allelic ratio is associated with outcome and ex vivo response to FLT3 inhibitors in pediatric AML. Blood. 131(22). 2485–2489. 27 indexed citations
6.
Moors, Ine, Karl Vandepoele, Jan Philippé, et al.. (2018). Clinical implications of measurable residual disease in AML: Review of current evidence. Critical Reviews in Oncology/Hematology. 133. 142–148. 16 indexed citations
7.
Vandepoele, Karl, Araceli Diez‐Fraile, Katrien Vandemeulebroecke, et al.. (2018). Pinpointing a potential role for CLEC12B in cancer predisposition through familial exome sequencing. Pediatric Blood & Cancer. 66(2). e27513–e27513. 5 indexed citations
8.
Vandepoele, Karl, et al.. (2018). A case of chronic eosinophilic leukemia with secondary transformation to acute myeloid leukemia. Leukemia Research Reports. 9. 45–47. 5 indexed citations
9.
Flórez, María R., Marta Costas‐Rodríguez, Karl Vandepoele, et al.. (2017). Whole blood Fe isotopic signature in a sub-Saharan African population. Metallomics. 9(8). 1142–1149. 9 indexed citations
10.
Philippé, Jan, et al.. (2017). Cancer‐related mRNA expression analysis using a novel flow cytometry‐based assay. Cytometry Part B Clinical Cytometry. 94(4). 565–575. 4 indexed citations
11.
12.
Willemse, Brigitte W.M., Karl Vandepoele, Jacobien A. Noordhoek, et al.. (2016). Protocadherin-1 Localization and Cell-Adhesion Function in Airway Epithelial Cells in Asthma. PLoS ONE. 11(10). e0163967–e0163967. 20 indexed citations
13.
Andries, Vanessa, Karl Vandepoele, Katrien Staes, et al.. (2015). NBPF1, a tumor suppressor candidate in neuroblastoma, exerts growth inhibitory effects by inducing a G1 cell cycle arrest. BMC Cancer. 15(1). 391–391. 31 indexed citations
14.
Vandepoele, Karl, Jan Philippé, & Barbara Denys. (2015). The YPEL5–PPP1CB fusion transcript is detected in different hematological malignancies and in normal samples. Leukemia Research Reports. 4(2). 51–54. 6 indexed citations
15.
Vandepoele, Karl, et al.. (2013). Delta-Protocadherins in Health and Disease. Progress in molecular biology and translational science. 116. 169–192. 37 indexed citations
16.
Vandepoele, Karl, Katrien Staes, Vanessa Andries, & Frans van Roy. (2010). Chibby interacts with NBPF1 and clusterin, two candidate tumor suppressors linked to neuroblastoma. Experimental Cell Research. 316(7). 1225–1233. 24 indexed citations
17.
Vandepoele, Karl, Vanessa Andries, & Frans van Roy. (2009). The NBPF1 Promoter Has Been Recruited from the Unrelated EVI5 Gene Before Simian Radiation. Molecular Biology and Evolution. 26(6). 1321–1332. 15 indexed citations
18.
Vandepoele, Karl, Vanessa Andries, Nadine Van Roy, et al.. (2008). A Constitutional Translocation t(1;17)(p36.2;q11.2) in a Neuroblastoma Patient Disrupts the Human NBPF1 and ACCN1 Genes. PLoS ONE. 3(5). e2207–e2207. 41 indexed citations
19.
Vandepoele, Karl & Frans van Roy. (2007). Insertion of an HERV(K) LTR in the intron of NBPF3 is not required for its transcriptional activity. Virology. 362(1). 1–5. 7 indexed citations
20.
Vandepoele, Karl, Nadine Van Roy, Katrien Staes, Frank Speleman, & Frans van Roy. (2005). A Novel Gene Family NBPF: Intricate Structure Generated by Gene Duplications During Primate Evolution. Molecular Biology and Evolution. 22(11). 2265–2274. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cecilia Surace Breakdown of academic impact, for papers by Rodney Staggs Breakdown of academic impact, for papers by Pietro Sirleto Breakdown of academic impact, for papers by Josef Davidsson Breakdown of academic impact, for papers by P. Mollevanger Breakdown of academic impact, for papers by Nicole L. Hoppman Breakdown of academic impact, for papers by Philippe Coullin Breakdown of academic impact, for papers by Patrick A. Ozark Breakdown of academic impact, for papers by Vasilios Zachariadis Breakdown of academic impact, for papers by Jürgen Groet
Rankless by CCL
2026